Business Wire

Groundbreaking New Sensor Transforms How Europe Tracks Pollution, Smoke and Cloud From Space

16.9.2025 10:00:00 EEST | Business Wire | Press release

Share

The first images from the Multi-Viewing, Multi-Channel, Multi-Polarisation Imager, presented at the 2025 EUMETSAT Conference, reveal the brand-new instrument’s exceptional ability to monitor the Earth’s atmosphere from multiple perspectives, to support improved forecasts and air pollution and climate monitoring.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915322837/en/

3MI’s very first image, captured between 10:59 and 11:03 CEST on 28 August 2025, confirmed the instrument is already performing well as it delivers its preliminary data streams. The left panel shows a standard view using natural light, highlighting clouds and land surfaces. The right panel, based on polarised light measurements, reveals much finer detail of the atmosphere’s composition – such as subtle cloud structures over Italy and wildfire smoke on the right edge of the image, over Greece. When sunlight interacts with particles in the air, like droplets, smoke or dust, the scattered light vibrates in specific directions, a property called polarisation. By capturing this perspective, 3MI provides richer insight into the type and size of particles in the atmosphere. Credit: EUMETSAT

Air pollution remains the leading environmental health risk in Europe, with exposure to fine particulate matter, nitrogen dioxide and ground-level ozone linked to more than 350,000 premature deaths across European Union countries in 2022. A powerful new European satellite instrument has now returned its first images from space, offering a new window into the atmosphere and the particles that influence our health, weather and climate.

On the opening day of the 30th edition of the EUMETSAT Meteorological Satellite Conference, experts revealed the first images from the Multi-Viewing, Multi-Channel, Multi-Polarisation Imager (3MI), which is designed to observe multiple signatures of the Earth’s atmosphere at once. When operational, the data streams from 3MI will support more accurate forecasts, better air quality and climate monitoring, and improved public health protection across Europe and beyond.

3MI, which sits on board the recently launched Metop Second Generation A1 (Metop-SGA1) satellite, began capturing images on 28 August 2025, just over two weeks after the launch of the satellite. The first images reveal fine atmospheric features with remarkable precision, including smoke from devastating wildfires in Southern Europe, and stunning rainbow cloud structures over Peru and Chile.

3MI is the result of more than 15 years of collaborative work by EUMETSAT, the European Space Agency, Leonardo, Airbus Defence and Space, and an international network of partners. It is Europe’s first operational polarimeter in space and one of only a few worldwide, building on the legacy of the Polarisation and Directionality of the Earth's Reflectances (POLDER) instrument – a mission led by the French space agency (CNES), which demonstrated how polarised light could provide valuable insights into atmospheric particles such as smoke, dust and salt, as well as clouds structures.

3MI now brings this capability into Europe’s operational weather satellite infrastructure and will provide continuous data for years to come, with the first images following successful recent high-quality data releases from other Metop-SGA1 instruments, the Microwave Sounder and the Radio Occultation Sounder.

Phil Evans, Director-General of EUMETSAT, said: “2024 was the hottest year ever recorded, in Europe and globally, and European countries are increasingly seeing weather extremes marked by devastating heat, drought, floods, fires and violent storms. From high above Earth, meteorological satellites can reveal the scale and fine detail of some of the world’s most critical weather and climate stories. That perspective is reflected in this year’s conference theme, from space to safety. The discussions in Lyon will explore how satellite data can be used to improve forecasts, strengthen responses to climate change and enable national and regional bodies to deliver services that protect lives, property and economies. By bringing together such a diverse community, it can forge better connections and knowledge that turn data into action for people across Europe and around the world.”

Virginie Schwarz, Chief Executive Officer of Météo-France, said: “Governments, businesses and citizens need reliable weather and climate services more than ever. For the weather and climate services provided by Météo-France, meteorological satellite data are indispensable, providing more than 90% of the information that goes into our global numerical weather prediction model. They support our forecasts and climate monitoring and give decision makers the knowledge they need to take faster, more effective action as climate change drives more extreme weather events. What makes this conference so important is the chance to share ideas, learn from each other and strengthen partnerships. Delegates will leave not only with fresh insights, but with connections that will last well beyond the week we spend together in Lyon.”

For more information, see the EUMETSAT website.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250915322837/en/

Contacts

Media Relations EUMETSAT:
Tel. : +49 6151 807 7320
Email: press@eumetsat.int
www.eumetsat.int -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.eumetsat.in
t&esheet=54324300&newsitemid=20250915322837&lan=en-US&anchor=www.eumetsat.int&in
dex=4&md5=4169b28a13b66eae00d8379c07f896cc

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye